Abstract:Background The basal ganglia are important structures for the release of dopamine in the limbic circuits of the midbrain, and the striatum and globus pallidus are the major nuclei of the basal ganglia, and the dysfunction of these regions has been the basis of many models that have attempted to explain the underlying mechanisms of schizophrenia symptoms. The purpose of this study was to investigate the changes in the volume of the striatum subregion and globus pallidus in three different stages of schizophrenia, and to analyze whether these volume changes were related to antipsychotic drugs and schizophrenia symptoms. Methods In this study, we investigated the volume of the striatum and globus pallidus in patients with schizophrenia at three different stages. The study included 57 patients with first-episode schizophrenia (FSZ), 51 patients with early-stage schizophrenia (ESZ), 86 patients with chronic schizophrenia (CSZ), and 191 healthy controls (HC), all of whom underwent structured magnetic resonance imaging (MRI) scans. Covariance analysis was performed using SPSS 26.0 was used for covariance analysis to determine whether there were significant differences in striatal subregion and globus pallidus volume between groups, and stratified analysis was used to further eliminate the effect of age on brain volume. Finally, the correlation analysis between the region of interest and the cumulative dose of antipsychotic drugs and psychotic symptoms was performed. Results The comparison between the different stages of the illness showed significant volume differences in the left caudate nucleus (lCAU) ( F = 2.665, adjusted p = 0.048), left putamen (lPUT) ( F = 12.749, adjusted p < 0.001), left pallidum (lPAL) ( F = 41.111, adjusted p < 0.001), and right pallidum (rPAL) ( F = 14.479, adjusted p < 0.001). Post-hoc analysis with corrections showed that the volume differences in the lCAU subregion disappeared. Further stratified analysis controlling for age showed that compared with the HC, the lPAL ( t = 4.347, p < 0.001) was initially significantly enlarged in the FSZ group, the lPUT ( t = 4.493, p < 0.001), rPUT ( t = 2.190, p = 0.031), lPAL ( t = 7.894, p < 0.001), and rPAL ( t = 4.983, p < 0.001) volumes were all significantly increased in the ESZ group, and the lPUT ( t = 3.314, p = 0.002), lPAL ( t = 6.334, p < 0.001), and rPAL ( t = 3.604, p < 0.001) subregion volumes were also significantly increased in the CSZ group. Correlation analysis showed that lPUT and bilateral globus pallidus were associated with cumulative dose of antipsychotics, but were not associated with clinical symptoms in each subregion. Conclusion The findings suggest that different subregions of the striatum and globus pallidus show significant volume differences at different stages of schizophrenia compared to HC. These volume differences may be strong radiographic evidence for schizophrenia. In addition, the lPAL was the only significantly different brain region observed in the FSZ group, suggesting that it may be a sensitive indicator of early brain structural changes in schizophrenia. Finally, our findings support the hypothesis that antipsychotic drugs have an effect on the volume of brain structures.

Choroid Plexus Enlargement and Allostatic Load in Schizophrenia.

Allostatic Load Effects on Cortical and Cognitive Deficits in Essentially Normotensive, Normoweight Patients with Schizophrenia

Neuronal Dysfunction in Individuals at Early Stage of Schizophrenia, A Resting-State Fmri Study

Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia

O6.3. PATTERNS OF GRAY MATTER ABNORMALITIES IN PATIENTS WITH FIRST-EPISODE AND TREATMENT-NAïVE SCHIZOPHRENIA

Association of Choroid Plexus Enlargement with Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum.

Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.

Investigation of choroid plexus variability in schizophrenia-spectrum disorders - insights from a multimodal study

Prognostic Utility of Multivariate Morphometry in Schizophrenia.

Association Of Cerebral Deficits With Clinical Symptoms In Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry And Resting State Functional Connectivity Study

Striatum and globus pallidus structural abnormalities in schizophrenia: A retrospective study of the different stages of the disease

Compensatory thickening of cortical thickness in early stage of schizophrenia

Correlation of allostatic load and perceived stress with clinical features in first-episode schizophrenia

Cortical and subcortical brain morphometry abnormalities in youth at clinical high-risk for psychosis and individuals with early illness schizophrenia

Altered Cortical Thickness Related to Clinical Severity but Not the Untreated Disease Duration in Schizophrenia.

Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis

Early-Course Unmedicated Schizophrenia Patients Exhibit Elevated Prefrontal Connectivity Associated with Longitudinal Change

Structural and functional abnormalities across clinical stages of psychosis: A multimodal neuroimaging investigation

Subcortical Brain Volume Abnormalities in 2028 Individuals with Schizophrenia and 2540 Healthy Controls Via the ENIGMA Consortium

Correlation between allostatic load and clinical characteristics of first-episode schizophrenia and its influence upon the onset

Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk for psychosis: A multisite neuroimaging study